Telesis Bio, Inc. (NASDAQ:TBIO) shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences. The partnership integrates Telesis Bio’s Gibson ...
Shares of Telesis Bio, Inc. TBIO rose sharply in today's pre-market trading session after the company announced a partnership ...
A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.
Beckman Coulter Diagnostics, a leader in clinical diagnostics, and Scopio Labs, a medtech company specialising in digital ...
BREA, Calif. and TEL AVIV, Israel, Sept. 17, 2024 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow ...
there have been 52 years of successful innovation using the Coulter Principle, making Beckman Coulter one of the leading companies in particle characterization today. The Multisizer™ 4 features ...